ABUS - Arbutus Biopharma says its CEO William Collier will retire November, 07 2023 08:47 AM Arbutus Biopharma Corporation 2023-11-07 08:47:44 ET More on Arbutus Biopharma Putting Arbutus Biopharma Back In The Spotlight Alnylam sends Arbutus lower after FDA snub for amyloidosis drug For further details see: Arbutus Biopharma says its CEO William Collier will retire